Industry / India
Ranbaxy Releases Ulcer Drug In The US
July 2008 | Industry NewsRanbaxy Pharmaceuticals has announced that it has launched a generic 40 mg version of ulcer drug Prilosec (omeprazole) in the US under an agreement with AstraZeneca . The drug reportedly had Q108 sales of US$204.2mn in the US according to IMS data.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
